Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues

Published:2009-01 Issue:1 Volume:11 Page:48-53
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Muros María Angustias,Varsavsky Mariela,Iglesias Rozas Pablo,Valdivia Javier,Delgado Juan Ramón,Forrer Flavio,Bodei Lisa,Paganelli Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-009-0310-5.pdf

Reference23 articles.

1. Clark O, Ajani JA, Kulke M et al (2005) Neuroendocrine tumors. In: National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology

2. Barakat MT, Meeran K, Bloom SR (2004) Neuroendocrine tumours. Endocr Relat Cancer 11:1–18

3. Valdes Olmos RA, Hoefnagel CA, Bais E et al (2001) Avances terapeúticos de medicina nuclear en Oncología. Rev Esp Med Nucl 20:547–557

4. Cremonesi M, Ferrari M, Zoboli S et al (1999) Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)YDOTATOC. Eur J Nucl Med 26:877–886

5. Waldherr C, Pless M, Maecke HR et al (2001) The clinical value of [90YDOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study. Ann Oncol 12:941–945

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours;Radiotherapy and Oncology;2019-12

2. Multislice PET/CT in Neuroendocrine Tumors;Multislice CT;2017

3. Glucagonoma Pancreatic Neuroendocrine Tumor Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy;Clinical Nuclear Medicine;2015-11

4. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors;Cancer and Metastasis Reviews;2015-08-06

5. Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications;Chemical Reviews;2015-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3